#pancreaticcancer is a deadly disease. New #trial data shows early benefits for addition of a personalized #mRNA #vaccine to #adjuvantchemotherapy after resection of the tumor. This feature in Deutsche Welle discusses the implications with Nina Bhardwaj and Drew Weissman #Immunotherapy #oncology https://t.co/j81AOXjcJS

#pancreaticcancer or #PancreaticDuctalAdenoCarcinoma is a still an extreme challenge in #Oncology. New insights on #adjuvantchemotherapy after resection and prior #neoadjuvant #chemotherapy suggest a new direction, but many questions remain...what type of chemotherapy or what type of patient is able to go through this treatment?
https://ja.ma/3iKFwNN

Referenced link: https://medicalxpress.com/news/2022-12-largest-kind-reveals-adjuvant-chemotherapy.html
Discuss on https://discu.eu/q/https://medicalxpress.com/news/2022-12-largest-kind-reveals-adjuvant-chemotherapy.html

Originally posted by Phys.org / @physorg_com@twitter.com: https://twitter.com/medical_xpress/status/1600894237909958656#m

RT by @physorg_com: Largest study of its kind reveals #adjuvantchemotherapy improves overall survival for #pancreaticcancer patients @CUAnschutz @JAMAOnc https://jamanetwork.com/journals/jamaoncology/fullarticle/2799187 https://medicalxpress.com/news/2022-12-largest-kind-reveals-adjuvant-chemotherapy.html